The small members of the JMJD protein family: Enzymatic jewels or jinxes?

S Oh, S Shin, R Janknecht - Biochimica et Biophysica Acta (BBA)-Reviews …, 2019 - Elsevier
S Oh, S Shin, R Janknecht
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 2019Elsevier
Jumonji C domain-containing (JMJD) proteins are mostly epigenetic regulators that
demethylate histones. However, a hitherto neglected subfamily of JMJD proteins,
evolutionarily distant and characterized by their relatively small molecular weight, exerts
different functions by hydroxylating proteins and RNA. Recently, unsuspected proteolytic
and tyrosine kinase activities were also ascribed to some of these small JMJD proteins,
further increasing their enzymatic versatility. Here, we discuss the ten human small JMJD …
Abstract
Jumonji C domain-containing (JMJD) proteins are mostly epigenetic regulators that demethylate histones. However, a hitherto neglected subfamily of JMJD proteins, evolutionarily distant and characterized by their relatively small molecular weight, exerts different functions by hydroxylating proteins and RNA. Recently, unsuspected proteolytic and tyrosine kinase activities were also ascribed to some of these small JMJD proteins, further increasing their enzymatic versatility. Here, we discuss the ten human small JMJD proteins (HIF1AN, HSPBAP1, JMJD4, JMJD5, JMJD6, JMJD7, JMJD8, RIOX1, RIOX2, TYW5) and their diverse physiological functions. In particular, we focus on the roles of these small JMJD proteins in cancer and other maladies and how they are modulated in diseased cells by an altered metabolic milieu, including hypoxia, reactive oxygen species and oncometabolites. Because small JMJD proteins are enzymes, they are amenable to inhibition by small molecules and may represent novel targets in the therapy of cancer and other diseases.
Elsevier